Login
$CORT
$69.22 -$3.72 (5.1%) Live

$CORT SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Swisher Daniel N Jr, Director

Received 1,500 shares by exercise or conversion ($19.7K) · Sold 1,500 shares ($111K)

10 Nov 2026 144
04 Nov 2026 Form 4: Maduck Sean, See Remarks

Received 11,841 shares by exercise or conversion ($97.9K) · Sold 11,841 shares ($964K) · Received 13,159 shares by exercise or conversion ($109K) · 1 more

04 Nov 2026 Form 4: Vieira Roberto Wandenkolk, President, Oncology

Received 8,333 shares by exercise or conversion ($180K) · Sold 8,333 shares ($674K)

03 Nov 2026 10-Q
03 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

REDWOOD CITY, Calif., (November 3, 2026) – Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neur...

27 Oct 2026 SCHEDULE 13G/A
16 Oct 2026 Form 4: Wilson James N, Director

Sold 10,000 shares ($1.15M)

05 Oct 2026 Form 4: Vieira Roberto Wandenkolk, President, Oncology

Received 8,333 shares by exercise or conversion ($180K) · Sold 8,333 shares ($967K)

05 Oct 2026 Form 4: Lyon Joseph Douglas, See Remarks

Received 810 shares by exercise or conversion ($11K) · Sold 810 shares ($93.5K) · Received 9,190 shares by exercise or conversion ($158K) · 1 more

05 Oct 2026 Form 4: Maduck Sean, See Remarks

Received 413 shares by exercise or conversion ($3.42K) · Sold 413 shares ($47.7K) · Received 24,587 shares by exercise or conversion ($203K) · 1 more

05 Oct 2026 Form 4: Gunn Justin Frederick, See Remarks

Granted 100,000 Stock Option (right to buy)

05 Oct 2026 Form 3: Gunn Justin Frederick, See Remarks

Holds 12,191 shares of Common Stock

01 Oct 2026 144
28 Sep 2026 Form 4: Robb Gary Charles, Chief Business Officer

Gave 17,100 shares as a gift · Acquired 10,000 shares (Gift)

23 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

REDWOOD CITY, Calif. – September 23, 2026 – Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neu...

18 Sep 2026 Form 4: Vieira Roberto Wandenkolk, President, Oncology

Sold 296 shares ($29.8K)

18 Sep 2026 Form 4: Robb Gary Charles, Chief Business Officer

Received 17,493 shares by exercise or conversion ($145K)

16 Sep 2026 Form 4: Lyon Joseph Douglas, See Remarks

Received 10,000 shares by exercise or conversion ($130K) · Sold 10,000 shares ($1.13M)

16 Sep 2026 Form 4: Wilson James N, Director

Sold 10,000 shares ($1.11M)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support